nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Book review
|
Sessa, C. |
|
|
8 |
6 |
p. 618 |
artikel |
2 |
Book review
|
Cerny, T. |
|
|
8 |
6 |
p. 510 |
artikel |
3 |
Central nervous system relapse of lymphoid malignancies in adults: The role of high-dose chemotherapy
|
van Besien, K. |
|
|
8 |
6 |
p. 515-524 |
artikel |
4 |
Central nervous system relapse of lymphoid malignancies in adults: Therole of high-dose chemotherapy
|
K. van Besien |
|
1997 |
8 |
6 |
p. 515-524 10 p. |
artikel |
5 |
Contents of the next issue
|
|
|
|
8 |
6 |
p. vii |
artikel |
6 |
Copyright
|
|
|
|
8 |
6 |
p. v |
artikel |
7 |
Delayed emesis induced by moderately emetogenic chemotherapy: Do we need to treat all patients?
|
Ballatori, E. |
|
|
8 |
6 |
p. 561-567 |
artikel |
8 |
Delayed emesis induced by moderately emetogenic chemotherapy: Do we needto treat all patients?
|
The Italian Group for Antiemetic Research |
|
1997 |
8 |
6 |
p. 561-567 7 p. |
artikel |
9 |
Dr. Fisher cleared of misconduct charges
|
|
|
|
8 |
6 |
p. 506-507 |
artikel |
10 |
EBMT in Aix-les-Bains
|
|
|
|
8 |
6 |
p. 506 |
artikel |
11 |
Editorial Board
|
|
|
|
8 |
6 |
p. vi |
artikel |
12 |
Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomised trial
|
Smyth, J.F. |
|
|
8 |
6 |
p. 569-573 |
artikel |
13 |
Glutathione reduces the toxicity and improves quality of life of womendiagnosed with ovarian cancer treated with cisplatin: Results of adouble-blind, randomised trial
|
J. F. Smyth |
|
1997 |
8 |
6 |
p. 569-573 5 p. |
artikel |
14 |
How to predict carboplatin clearance from standard morphological and biological characteristics in obese patients
|
Bénézet, S. |
|
|
8 |
6 |
p. 607-609 |
artikel |
15 |
How to predict carboplatin clearance from standard morphological andbiological characteristics in obese patients
|
S. Bénézet |
|
1997 |
8 |
6 |
p. 607-609 3 p. |
artikel |
16 |
Instructions to authors
|
|
|
|
8 |
6 |
p. 619-620 |
artikel |
17 |
In this issue
|
|
|
|
8 |
6 |
p. vii |
artikel |
18 |
Letters to the editor
|
|
|
1997 |
8 |
6 |
p. 615-618 4 p. |
artikel |
19 |
Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients
|
Falcone, A. |
|
|
8 |
6 |
p. 539-545 |
artikel |
20 |
Maximum tolerable doses of intravenous zidovudine in combination with5-fluorouracil and leucovorin in metastatic colorectal cancer patients
|
A. Falcone |
|
1997 |
8 |
6 |
p. 539-545 7 p. |
artikel |
21 |
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy
|
Hidalgo, M. |
|
|
8 |
6 |
p. 555-559 |
artikel |
22 |
Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated withcisplatin-based combination chemotherapy
|
M. Hidalgo |
|
1997 |
8 |
6 |
p. 555-559 5 p. |
artikel |
23 |
Neurologic complications of Hodgkin's disease: A case history
|
Abate, G. |
|
|
8 |
6 |
p. 593-600 |
artikel |
24 |
Neurologic complications of Hodgkins disease: A case history
|
G. Abate |
|
1997 |
8 |
6 |
p. 593-600 8 p. |
artikel |
25 |
News
|
A. Abbott |
|
1997 |
8 |
6 |
p. 505-510 6 p. |
artikel |
26 |
Perhaps not everyone knows that…
|
|
|
|
8 |
6 |
p. 509-510 |
artikel |
27 |
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification
|
Ascani, S. |
|
|
8 |
6 |
p. 583-592 |
artikel |
28 |
Peripheral T-cell lymphomas. Clinico-pathologic study of 168 casesdiagnosed according to the R.E.A.L. Classification
|
S. Ascani |
|
1997 |
8 |
6 |
p. 583-592 10 p. |
artikel |
29 |
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation
|
Judson, I. |
|
|
8 |
6 |
p. 604-606 |
artikel |
30 |
Phase II trial of the oral platinum complex JM216 in non-small-cell lungcancer: An EORTC early clinical studies group investigation
|
I. Judson |
|
1997 |
8 |
6 |
p. 604-606 3 p. |
artikel |
31 |
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors*
|
Hartmann, J.T. |
|
|
8 |
6 |
p. 531-538 |
artikel |
32 |
Postchemotherapy resections of residual masses from metastaticnon-seminomatous testicular germ cell tumors
|
J. T. Hartmann |
|
1997 |
8 |
6 |
p. 531-538 8 p. |
artikel |
33 |
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study*
|
Peiffert, D. |
|
|
8 |
6 |
p. 575-581 |
artikel |
34 |
Preliminary results of a phase II study of high-dose radiation therapyand neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy forpatients with anal canal cancer: A French cooperative study
|
D. Peiffert |
|
1997 |
8 |
6 |
p. 575-581 7 p. |
artikel |
35 |
Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients
|
Maestu, I. |
|
|
8 |
6 |
p. 547-553 |
artikel |
36 |
Pretreatment prognostic factors for survival in small-cell lung cancer:A new prognostic index and validation of three known prognostic indices on 341patients
|
I. Maestu |
|
1997 |
8 |
6 |
p. 547-553 7 p. |
artikel |
37 |
Reshaping Italian AIDS research
|
|
|
|
8 |
6 |
p. 508-509 |
artikel |
38 |
Sexuality in women receiving chemotherapy for breast cancer
|
Valle, J. |
|
|
8 |
6 |
p. 616-617 |
artikel |
39 |
Shake-up for New York's cancer centers
|
|
|
|
8 |
6 |
p. 507-508 |
artikel |
40 |
Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions
|
Bookman, M.A. |
|
|
8 |
6 |
p. 611-614 |
artikel |
41 |
Short-course intravenous prophylaxis for paclitaxel-relatedhypersensitivity reactions
|
M. A. Bookman |
|
1997 |
8 |
6 |
p. 611-614 4 p. |
artikel |
42 |
Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
|
Manegold, C. |
|
|
8 |
6 |
p. 525-529 |
artikel |
43 |
Single-agent gemcitabine versus cisplatinetoposide: Early resultsof a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
|
C. Manegold |
|
1997 |
8 |
6 |
p. 525-529 5 p. |
artikel |
44 |
Table of Contents
|
|
|
|
8 |
6 |
p. iv-v |
artikel |
45 |
The control of delayed nausea
|
Roila, F. |
|
|
8 |
6 |
p. 615 |
artikel |
46 |
The increased armament in the battle against non-small-cell lung cancer
|
SØrensen, J.B. |
|
|
8 |
6 |
p. 513-514 |
artikel |
47 |
The increased armament in the battle against non-small-cell lungcancer
|
J.B. Sørensen |
|
1997 |
8 |
6 |
p. 513-514 2 p. |
artikel |
48 |
The strategy of the Commission for cancer research
|
Abbott, A. |
|
|
8 |
6 |
p. 505 |
artikel |
49 |
This letter was referred to the authors, who respond as follows:
|
Barni, S. |
|
|
8 |
6 |
p. 617-618 |
artikel |
50 |
This letter was referred to the authors, who respond as follows:
|
Olver, I. |
|
|
8 |
6 |
p. 615-616 |
artikel |
51 |
Tightened rules for testing new drugs in Japan
|
|
|
|
8 |
6 |
p. 507 |
artikel |
52 |
Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine
|
Advani, R. |
|
|
8 |
6 |
p. 601-603 |
artikel |
53 |
Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine
|
R. Advani |
|
1997 |
8 |
6 |
p. 601-603 3 p. |
artikel |
54 |
What are the goals of the CONSORT initiative and what will it achieve?
|
Williams, C. |
|
|
8 |
6 |
p. 511-512 |
artikel |
55 |
What are the goals of the CONSORT initiative and what will it achieve?
|
C. Williams |
|
1997 |
8 |
6 |
p. 511-512 2 p. |
artikel |